|
Volumn 685, Issue 1, 1996, Pages 159-164
|
Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography
a a a a |
Author keywords
NU ICRF 505; Topoisomerase I inhibitor
|
Indexed keywords
ANTHRAQUINONE DERIVATIVE;
ANTINEOPLASTIC AGENT;
DRUG METABOLITE;
ENZYME INHIBITOR;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CALIBRATION;
CELL CULTURE;
COLON CANCER;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG TISSUE LEVEL;
HUMAN;
HUMAN TISSUE;
IN VITRO STUDY;
INTRAPERITONEAL DRUG ADMINISTRATION;
LIVER;
MOUSE;
NONHUMAN;
NORMAL HUMAN;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SPECTROPHOTOMETRY;
TECHNIQUE;
TUMOR;
TUMOR CELL;
|
EID: 0030580049
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/0378-4347(96)00155-7 Document Type: Article |
Times cited : (6)
|
References (12)
|